Next-generation pharma company using computationally designed therapeutics and automated clinical trials to advance RNA, antibody, and small-molecule programs.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2022
Nov 2022
Oct 2022
Apr 2021
Apr 2021
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
BridgeBio makes targeted treatments for genetic diseases.
